Further, we have determined that glucocorticoid exposure during this window of development results in dysregulation of insulin and IGF1 signaling and an adaptive immune response in the TE, suggesting the potential development of altered placental capacity and metabolic disease later in life. Here, IGF1 is linked to metabolic disease.